Wednesday, January 31, 2024

Muckle-Wells Syndrome (NLRP3) sequencing, total blood

Description, Method, Delivery time and Mnemonic Modification

Test code: 4114

Previous Mnemonic code: G1124
New Mnemonic code: G17019

Effective update from 12/02/2024



PREVIOUS

NEW
Muckle-Wells Syndrome (NLRP3) sequencing, total blood 

Method: Sequencing

Delivery time: 30 days       
     
Version of Test: 7
     
MUCKLE-WELLS SYNDROME · NLRP3 · SANGER        

Method: Sanger Sequencing 

Delivery time: 32 days           
     
Version of Test: 8

   Find the record of the test by clicking here

TRIO WHOLE EXOME + MITOCHONDRIAL GENOME

New Test in NOÛS Catalog

Test Code: 9974

Sample:
Biological Sample
Conservation:
Refrigerated
Method:
Next Generation Sequencing (NGS)
Set Up Days:
Daily
Delivery term:
42 days

    Find the record of the test by clicking here

Friday, January 26, 2024

PENTACHLORPHENOL, URINE

Reference values Modification

Test code: 6048
Mnemonic code: CFOR

Effective update from 05/02/2024




PREVIOUS

NEW
        
      B.E.I.: 25 mg/g creatinine
     
     
     
     
      Version of Test: 9
     


  Exposure to Chlorobenzene
  BEI (ACGIH) in end-of-workday urine: Less than 20 mg/g creatinine
  LoQ: 1 mg/L
  *Source: ACGIH - American Conference of Governmental Industrial Hygienists"

  Version of Test: 10
     


   Find the record of the test by clicking here

FACTOR Xa (ANTI ACTIVATED), PLASMA

Description and Reference values Modification

Test code: 4343
Mnemonic code: FACX

Effective update from 05/02/2024




PREVIOUS

NEW
        
      
      Description: FACTOR Xa (ANTI ACTIVATED), PLASMA
     
      Reference Values:
      UFH (unfractionated heparin):
     
      0.3 - 0.7 UI/mL
     
      LMWH (low molecular weight heparin):
     
      Every 12h: 0.6 - 1.0 UI/mL
      Every 24h: 1.0 - 2.0 UI/mL
     
      * Rest of anticoagulants: Result interpretation according to the anticoagulant used, dose and time elapsed from last intake until the moment of sample extraction.
     
    
     
      Version of Test: 9
     


        
         
Description: ANTI FACTOR X ACTIVITY, PLASMA   
      
      
Reference Values:   
UFH (unfractionated heparin): 0.3 - 0.7 UI/mL
LMWH (low molecular weight heparin)therapeutic range: 0.6 - 1.0 UI/mL (HBPM every 12 hours)
       1.0 - 2.0 UI/mL (HBPM every 24 hours)         

         
         
         






    
     
      Version of Test: 10
     


   Find the record of the test by clicking here

DELTA AMINOLEVULINIC ACID DEHYDRATASE

Discontinued Temporarily

Test code: 9698
Mnemonic code: ALADH

Effective update from 29/01/2024

Test discontinued temporarily due to supply issues from the supplier laboratory.


                                         Find the record of the test by clicking here

COCLEARS P-68 kD (HSP-70) ANTIBODIES, SERUM

Delivery Time Modification

Test code: 7740
Mnemonic code: ACP68

Effective update from 29/01/2024




PREVIOUS

NEW
 
     
      Delivery term: 12 days
     
     
     

        
     
      Delivery term: 10 days
     
     

   Find the record of the test by clicking here

LEPTIN, SERUM

Sample (Only Nationa) and Reference values Modification

Test code: 3120
Mnemonic code: LEP

Effective update from 05/02/2024




PREVIOUS

NEW
        
      Sample (National): Frozen serum

      Reference Values
      Woman: 3.63 - 11.10 ng/mL
      Man : 2.05 - 5.63 ng/mL
      Valid values for CMI (Corporal Mass Index)
      between 18-25
     
      *Values are increased in base of corporal mass.
      *It is recommended periodical determinations,
      one isolated result is not valid.
     
     
      
     
     


     Version of Test: 8
     


  Sample (National): Refrigerated serum

  Reference Values:
  Adults
    BMI                Reference Values
    18.5 - 24.9        Less than 8.3 ng/mL
    25 - 30            Less than 19.3 ng/mL
    Greater than a 30  Less than 32.0 ng/mL

  Children (1 - 10 years)
    BMI               Reference Values
    Not determined    Less than 7.0 ng/mL

    *Values ara increased in base of corporal mass.
    **It is recommended periodical determinations, one isolated result is not valid.

    Source: PNT, Insert

    Version of Test: 9
     


   Find the record of the test by clicking here

Wednesday, January 24, 2024

ORGANIC ACIDS · SCREENING, URINE

Erased Test

Test code: 9861
Mnemonic code: AOOSC

Effective update from 05/02/2024

Alternative: 9949 (AOOEC) -  ORGANIC ACIDS STUDY, URINE

This study includes the qualitative analysis of 79 organic acids. Only the organic acids that show deviations in the initial review are quantified.

The analyzed organic acids are:
Lactic acid, Phenylpyruvic acid, Glyoxylic acid, Vanilinlactic acid, 2-hydroxysebacic acid, Oxalic acid, 2-oxoadipic acid, 3-hydroxyisobutyric acid, 3-hydroxysebacic acid, 2-methyl-3-hydroxybutyric acid, 5-hydroxyindoleacetic acid, Malonic acid, Suberylglycine, Acetoacetic acid, Succinylacetone, 3-hydroxyisovaleric acid, Hexanoylglycine, Methylmalonic acid, 2,3-dihydroxybutyric acid, 4-hydroxybutyric acid, Glycolic acid, Ethylmalonic acid, Thioglycolic acid, Methylsuccinic acid, Octenedioic acid, Glyceric acid, Hippuric acid, Fumaric acid, Decenedioic acid, Isobutyrylglycine, Vanilmandelic acid, 3-methylglutaric acid, Decanedioic acid, A.3-methylglutaconic acid, A.4-hydroxyphenyllactic acid, Isovalerylglycine, A.2-oxoglutaric acid, Malic acid, Phenylpropionylglycine, Adipic acid, N-acetyltyrosine, Mevalonic acid, A.4-hydroxyphenylpyruvic acid, Tiglylglycine, A.2-hydroxybutyric acid, A.2-hydroxyphenylacetic acid, A.3-hydroxypropionic acid, A.2-hydroxyglutaric acid, A.2-hydroxyisovaleric acid, A.3-hydroxyglutaric acid, A.2-ethyl-3-hydroxypropionic acid, A.3-hydroxy-3-methylglutaric acid, A.2-hydroxyisocaproic acid, N-acetylasparagic acid, A.3-hydroxyvaleric acid, A.2-hydroxyadipic acid, A.2-hydroxy-3-methylvaleric acid, Suberic acid, A.4-hydroxyisovaleric acid, Orotic acid, A.5-hydroxyhexanoic acid, Homovanillic acid, Glutaconic acid, A.3-hydroxybutyric acid, Mandelic acid, Glycerol, 5-Oxoproline, Succinic acid, A.3-methylcrotinylglycine, Uracil, A.phenyllactic acid, Glutaric acid, A.4-hydroxyphenylacetic acid, A.3-hydroxyadipic acid, Aconitic acid, Citric acid, Homogentisic acid, Methylcitric acid, Sebacic acid.

   Find the record of the test by clicking here

ZONISAMIDE, SERUM

Reference values Modification

Test code: 1553
Mnemonic code: ZONI

Effective update from 05/02/2024




PREVIOUS

NEW
        
      Therapeutic level:
      20 - 40 mg/L
      LoQ: 0.5 mg/L
     
  
     
     
      Version of Test: 7
     


  Therapeutic level: 20 - 40  mg/L
  Toxicity : Greater than 40 mg/L
  LoQ : 4 mg/L
     
  *Source: Hiemke C et al. Consensus Guidelines for Therapeutic Drug Monitoring in Pharmacopsychiatry 2018; 51: 9–62. AGNP 2018.
     
     
      Version of Test: 8
     


   Find the record of the test by clicking here

Tuesday, January 23, 2024

VITELLIFORM MACULAR DYSTROPHY · PANEL · MLPA

New Test in NOÛS Catalog

Test Code: 9972

Sample:
Whole blood - EDTA (5 ml)
Conservation:
Refrigerated
Method:
Multiplex Ligation-dependent Probe Amplification-MLPA
Set Up Days:
Daily
Delivery term:
24 days

    Find the record of the test by clicking here

ANTI - MICROSOMAL HEPATIC/RENALS (LKM) ANTIBODIES, SERUM

Reference values Modification

Test code: 5203
Mnemonic code: LKM

Effective update from 05/02/2024




PREVIOUS

NEW
        
      Negative: Less than 1/10
     
     
     
     
      Version of Test: 3
     

        
      Negative: Less than 1/20   
      * Source: PNT, Insert   
     
     
     
      Version of Test: 4
     

   Find the record of the test by clicking here

Monday, January 22, 2024

LIMG-GIRDLE MUSCULAR DYSTROPHY AD TYPE 1B · LMNA · SANGER

New Test in NOÛS Catalog

Test Code: 9970

Sample:
Biological Sample
Conservation:
Refrigerated
Method:
Sanger sequencing
Set Up Days:
Daily
Delivery term:
32 days

    Find the record of the test by clicking here

Friday, January 19, 2024

ONCO IN BLOOD - DISCONTINUED TEMPORALY

Dicontinued temporaly

Temporary test suspension due to the temporary cessation of service by the supplier

Effective update from 22/01/2024



Código Prueba

Código nemónico

Prueba

5073

G15027

ONCO IN BLOOD · BRAF(V600E, V600K) · RT-PCR+PNA

5074

G15028

ONCO IN BLOOD · EGFR(19, 21, T790M) · RT-PCR+PNA

7354

G15029

ONCO IN BLOOD · EGFR (C797S) · RT-PCR+PNA

7356

G15030

ONCO IN BLOOD · EML4/ALK(var 1, 2, 3) · RT-PCR

5075

G15031

ONCO IN BLOOD · KRAS(2, 3) · RT-PCR+PNA

7365

G15032

ONCO IN BLOOD · MET(var splicing 7/8, var splicing 14) · RT-PCR

7361

G15033

ONCO IN BLOOD · PIK3CA(9,20) · RT-PCR+PNA

8257

G15110

ONCO IN BLOOD · EGFR (18, 19, 20, 21) · NGS

8726

G15137

BIOMARCADORES IN SOLIDS TUMORS · MET (splicing var 7/8; 14) · RT-PCR

9825

G15150

BLADDER  NEOPLASM · FGFR2, FGFR3 · NGS

9542

G15172

ONCO IN BLOOD · BRAF, KRAS, NRAS · NGS


   Find the record of the test by clicking here

Thursday, January 18, 2024

SIROLIMUS, WHOLE BLOOD

Reference values and Delivery Time Modification

Test code: 2792

Effective update from dd/mm/aa




PREVIOUS

NEW
        
      Kidney transplant
     
      Combination with steroids and mycophenolic acid:
      5 - 10 ng/mL
      Combination with steroids without mycophenolic acid:
      8 - 12 ng/mL
      Triple therapy with cyclosporine A, corticosteroids and sirolimus:
      4 - 12 ng/mL
      Dual therapy with corticosteroids and sirolimus:
      12 - 20 ng/mL
     
      Liver transplant
     
      Therapy with Cyclosporin A or tracolimus, sirolimus and, if necessary, corticosteroids:
      3 - 6 ng/mL
      Sirolimus therapy and, if necessary, coricosteroids:
      5 - 8 ng/mL
      *Source: PNT, Insert
     
      
     
     
      Version of Test: 17
     


      Kidney transplant
     
      Combination with steroids and mycophenolic acid:
      5 - 10 ng/mL
      Combination with steroids without mycophenolic acid:
      8 - 12 ng/mL
      Triple therapy with cyclosporine A, corticosteroids and sirolimus:
      4 - 12 ng/mL
      Dual therapy with corticosteroids and sirolimus:
      12 - 20 ng/mL
     
      Liver transplant
     
      Therapy with Cyclosporin A or tracolimus, sirolimus and, if necessary, corticosteroids:
      3 - 6 ng/mL
      Sirolimus therapy and, if necessary, coricosteroids:
      5 - 8 ng/mL

      LoQ: 2 ng/mL

      *Source: PNT, Insert 

      Version of Test: 18
     


   Find the record of the test by clicking here